Clinical trial
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With…
NCT00055484 · Elan Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00055484 |
|---|---|
| Title | A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache |
| Official title | A Double-Blind, Randomized, Multicenter, Parallel Dose Study to Evaluate the Safety and Efficacy of Zonisamide 150 mg and 300 mg Per Day and Placebo in Subjects With Migraine Headache |
| Lead sponsor | Elan Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Migraine Headache |
| Intervention type | Drug |
| Interventions | zonisamide |
| Enrollment | 204 |
| Start date | Mar 1, 2002 |
| Completion | May 1, 2003 |
| First posted | Mar 5, 2003 |
| Last update posted | Dec 14, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: